Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.580, 2009-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bevacizumab combination improves survival in advanced NSCLC
Inpharma, Vol. 1, Iss. 1492, 2005-01 ,pp. :
Access to resources
Recommend
Bevacizumab for NSCLC: benefits weighed against risks
Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. :
Bevacizumab "best value for money" in MCRC . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 666, 2012-01 ,pp. :
Can improving healthcare quality save money?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 588, 2009-01 ,pp. :